Most recent update: Monday, March 30, 2020 - 08:53

Bariatric News - Cookies & privacy policy

You are here

weight loss

IBT and liraglutide show positive results for weight loss

Intensive behavioural therapy (IBT) combined with liraglutide 3.0mg (Saxenda) can produce clinically-meaningful weight loss in patients who receive the treatment in predominantly primary care settings. The study is the first multi-site evaluation of the efficacy of IBT based on a treatment visit schedule covered by the Centers for Medicare and Medicaid Services (CMS).

Dietitians play an effective role in weight loss programmes

Intensive behavioural therapy from dietitians may be a very effective ways for older patients to lose weight, according to researchers who examined the integration of registered dietitian nutritionist-provided intensive behavioural therapy for obesity into a primary care setting and evaluated clinic outcomes for Medicare patients.

Insufficient evidence supporting herbal medicines with weight loss

There is currently insufficient evidence to recommend any of the herbal medicines for weight loss according to researchers from the University of Sydney, Australia, who conducted the first global review of herbal medicines for weight loss in 19 years.

Key strategies to maintaining sustained weight loss

A study by researchers from California Polytechnic State University, San Luis Obispo, California, US, has reported that that if you want to lose weight and keep it off, building healthy dietary, self-monitoring and psychological coping strategies may be the keys to success.

Sustained weight loss associated with reduced breast cancer risk

A large study has found that women who lost weight after age 50 and kept it off had a lower risk of breast cancer than women whose weight remained stable, helping answer a vexing question in cancer prevention. The reduction in risk increased with the amount of weight lost and was specific to women not using postmenopausal hormones.

Rediscovering the wheel in reporting on weight loss and other outcomes after BMS

Publications on outcomes of bariatric metabolic surgeries (BMS) are going through the phase of rediscovering the wheel. Obesity is a life long disease. From the later half of the 70s through the early nineties, the field of BMS was characterised by introduction of surgical procedures that were claimed to be effective and popularised because of observed initial significant weight loss in the first year only to be discarded a few years later because of poor weight loss maintenance and/or significant weight loss regain.

Studies demonstrate the effectiveness of post-op liraglutide

Liraglutide can be considered as a safe and effective adjunctive treatment to prevent weight regain after bariatric surgery, according to two studies presented at the UK’s Society for Endocrinology annual conference.

In the first study, ‘Efficacy of liraglutide in weight management post bariatric surgery patients: data from an Emirati cohort’, researchers from Imperial College London Diabetes Centre, Abu Dhabi, UAE, assessed the use of Liraglutide for relapse after bariatric surgery in an Emirati population.

Probiotic supplements could enhance weight loss in children

Probiotic supplements may enhance weight loss and improve the metabolic health of children with obesity following a diet and exercise plan, according to research presented at the 58th Annual European Society for Paediatric Endocrinology Meeting, in Vienna, Austria. The findings of this small trial suggest that probiotic supplements may help obese children lose body weight and also reduce their risk of future metabolic conditions, including type 2 diabetes and heart disease.

Elipse balloon presents significant weight loss at XXIV IFSO Congress

Allurion Technologies has announced results from three key abstracts presented at the 24th World IFSO Congress, which and show significant decreases in both weight and cardiovascular disease markers, such as LDL cholesterol and haemoglobin A1c, in patients who have used the balloon for weight loss. The Elipse Balloon, the world’s first and only procedureless medical device for weight loss, received its European Union CE mark in 2015 and is currently available at more than 100 weight loss centres in countries across Europe, the Middle East and South America.

Health is primary motivation for weight loss

A report by Australia's national science agency, CSIRO, has found that more people are more motivated by improving their health than their appearance, when it comes to weight loss, with two out of three people motivated to start a diet because of 'health concerns.' The survey of more than 3000 CSIRO Total Wellbeing Diet (TWD) online members also found around half of people who lost weight through the scientifically developed diet reported improvements in chronic health conditions such as type 2 diabetes and high cholesterol.

Subscribe to RSS - weight loss